Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Leo Pharma
Fierce Pharma
JPM26: Leo Pharma sharpens its eye for dermatology dealmaking
Leo Pharma CEO Christophe Bourdon is eager to make additional strides on the new era of growth he’s fostered since taking over in 2022.
Zoey Becker
Jan 13, 2026 2:45pm
Recursion refreshes leadership with CEO swap—Chutes & Ladders
Nov 7, 2025 8:30am
BMS oncology head swings to Syndax—Chutes & Ladders
May 16, 2025 8:30am
Leo's eczema prospect hits primary endpoint in phase 2b
May 9, 2025 7:30am
Gilead roars into JPM25 with $250M upfront deal for Leo
Jan 11, 2025 5:30pm
BenevolentAI names ex-Bayer R&D chief as new CEO
Jan 24, 2024 10:20am